Daniel Dhumeaux
#147,887
Most Influential Person Now
Daniel Dhumeaux's AcademicInfluence.com Rankings
Daniel Dhumeauxphilosophy Degrees
Philosophy
#8038
World Rank
#11343
Historical Rank
Logic
#5073
World Rank
#6433
Historical Rank

Download Badge
Philosophy
Daniel Dhumeaux's Degrees
- PhD Biomedical Sciences University of California, San Francisco
- Doctorate Medicine Stanford University
Why Is Daniel Dhumeaux Influential?
(Suggest an Edit or Addition)Daniel Dhumeaux's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. (2002) (6617)
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C (2005) (1426)
- Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. (2005) (569)
- Immunological disorders in C virus chronic active hepatitis: A prospective case‐control study (1994) (516)
- Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases (2006) (514)
- Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC (2006) (455)
- Characteristics of patients with dual infection by hepatitis B and C viruses. (1998) (396)
- Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. (1995) (378)
- Diagnosis of Hepatic Fibrosis and Cirrhosis by Transient Elastography in HIV/Hepatitis C Virus-Coinfected Patients (2006) (364)
- Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study (2002) (349)
- Extrahepatic Immunologic Manifestations in Chronic Hepatitis C and Hepatitis C Virus Serotypes (1995) (335)
- Epidemiological factors affecting the severity of hepatitis C virus‐related liver disease: A French survey of 6,664 patients (1997) (320)
- Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies (2003) (316)
- Management of focal nodular hyperplasia and hepatocellular adenoma in young women: A series of 41 patients with clinical, radiological, and pathological correlations (1995) (314)
- Laparoscopic Liver Resection for Peripheral Hepatocellular Carcinoma in Patients With Chronic Liver Disease: Midterm Results and Perspectives (2006) (300)
- Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C (2005) (300)
- Antiviral action of ribavirin in chronic hepatitis C. (2004) (273)
- Oral contraceptive use and focal nodular hyperplasia of the liver. (2000) (220)
- Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma (2005) (216)
- Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations (1998) (215)
- Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication (2002) (210)
- Mechanism of phenobarbital-induced hypercholeresis in the rat. (1970) (198)
- Standardization of Hepatitis C Virus RNA Quantification (2000) (186)
- Lichen planus and hepatitis C virus--related chronic active hepatitis. (1994) (184)
- Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture (1995) (184)
- Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. (2014) (173)
- Mechanisms and control of secretion of bile water and electrolytes. (1974) (170)
- Ursodeoxycholic acid for primary sclerosing cholangitis. (1990) (163)
- Effect of inhibitors of sodium transport on bile formation in the rabbit. (1970) (163)
- Lack of mother‐to‐infant transmission of hepatitis C virus in human immunodeficiency virus–seronegative women: A prospective study with hepatitis C virus RNA testing (1993) (139)
- Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis (2004) (138)
- What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? (1998) (137)
- Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. (1999) (137)
- Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. (1999) (131)
- Association of focal nodular hyperplasia and hepatic hemangioma. (1989) (130)
- Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro (2002) (128)
- Impact of smoking on histological liver lesions in chronic hepatitis C (2003) (125)
- Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. (1995) (124)
- Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study (2003) (122)
- Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients (2002) (121)
- Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. (1995) (115)
- In vitro toxicity of polymorphonuclear neutrophils to rat hepatocytes: Evidence for a proteinase‐mediated mechanism (1988) (112)
- Drug-induced vascular lesions of the liver. (1983) (110)
- Hepatitis C virus in dermatology. A review. (1995) (109)
- Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C (1998) (109)
- Mechanism of γ‐glutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: A histochemical, biochemical and molecular approach (1990) (106)
- Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial (1993) (105)
- Effect of rifampicin on liver function in man (1972) (105)
- Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections (2004) (104)
- ORTHOTOPIC LIVER TRANSPLANTATION WITH PRESERVATION OF THE CAVAL AND PORTAL FLOWS Technique and Results in 62 Cases (1994) (104)
- Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors. (1996) (103)
- Factors Affecting Treatment Responses to Interferon-α in Chronic Hepatitis C (1996) (102)
- Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. (1987) (94)
- Dynamics of Hepatitis B Virus Resistance to Lamivudine (2006) (94)
- Pulmonary Hypertension Complicating Portal Hypertension1, 2 (1979) (93)
- Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. (2000) (90)
- Histopathologic impact of GB virus C infection on chronic hepatitis C. (1997) (90)
- Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay (1997) (90)
- Evolution of the Hepatitis C Virus Second Envelope Protein Hypervariable Region in Chronically Infected Patients Receiving Alpha Interferon Therapy (1999) (89)
- Treatment of hepatitis C. The 2002 French consensus (2003) (88)
- Massive Blastic Infiltration of the Liver: A Cause of Fulminant Hepatic Failure (2007) (88)
- Hepatitis C virus infection and autoimmune thrombocytopenic purpura. (1995) (88)
- Pulmonary hypertension complicating portal hypertension. (1979) (87)
- Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. (1977) (87)
- High prevalence of hepatitis B, C, and E markers in young sexually active adults from The Central African Republic (1995) (86)
- Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation (1999) (85)
- Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay (1996) (85)
- Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. (1999) (81)
- Amiodarone‐induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease (1988) (80)
- Hepatocellular adenoma: color Doppler US and pathologic correlations. (1994) (79)
- Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study (1994) (79)
- Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria (1987) (79)
- Fibroblast growth factor 2 and transforming growth factor beta 1 interactions in human liver myofibroblasts. (1995) (78)
- Hepatitis C Virus-Induced Hepatocellular Steatosis (2005) (78)
- Efficacy and Safety of Two-Dose Regimens of Peginterferon Alpha-2a Compared with Interferon Alpha-2a in Chronic Hepatitis C: A Multicenter, Randomized Controlled Trial (2004) (76)
- Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis: A clinical and immune-logical study of a series of 150 patients with primary biliary cirrhosis (1990) (75)
- Antineoplastic agents and the liver (1980) (71)
- Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. (1988) (70)
- Antinuclear autoantibodies specific for lamins. Characterization and clinical significance. (1988) (67)
- Oral contraceptive intake in women with focal nodular hyperplasia of the liver (1998) (67)
- Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141). (2014) (64)
- Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy. (2002) (61)
- Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users (2006) (60)
- The impact of the prevention programme of hepatitis C over more than a decade: the French experience (2009) (60)
- Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA (1994) (58)
- Assessing the cost-effectiveness of hepatitis C screening strategies in France. (2018) (58)
- Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? (2002) (57)
- Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. (1988) (55)
- The hot spot hepatobiliary scan in focal nodular hyperplasia. (1993) (55)
- Orthotopic liver transplantation in the presence of partial or total portal vein thrombosis: Problems in diagnosis and management (1993) (54)
- An outbreak of hepatitis B in an endocrinology unit traced to a capillary-blood-sampling device. (1990) (53)
- MRI of atypical focal nodular hyperplasia of the liver: radiology-pathology correlation. (2004) (53)
- Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver (1995) (53)
- Lichen planus and hepatitis C virus (HCV)‐related chronic hepatitis: evaluation of HCV genotypes (1995) (51)
- Vascular lesions of the liver in sickle cell disease. A clinicopathological study in 26 living patients. (1995) (51)
- What technique should be used for routine detection and quantification of HBV DNA in clinical samples? (1997) (51)
- SERIAL QUANTITATIVE DETERMINATION OF HEPATITIS C VIRUS RNA LEVELS AFTER LIVER TRANSPLANTATION A USEFUL TEST FOR DIAGNOSIS OF HEPATITIS C VIRUS REINFECTION (1995) (50)
- The usefulness of microscopic bile examination in patients with suspected microlithiasis: A prospective evaluation (1986) (50)
- Should we screen blood products for hepatitis E virus RNA ? (2014) (49)
- Hepatic vein obstruction in idiopathic hypereosinophilic syndrome. (1985) (49)
- Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity. (1987) (46)
- Incidence of interferon alfa–induced depression in patients with chronic hepatitis C (2002) (45)
- Peginterferon alpha‐2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha‐2b (2006) (45)
- Oral contraceptives and the liver. (1972) (42)
- Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns (1995) (41)
- Antineoplastic agents and the liver. (1980) (40)
- Chronic liver disease after low daily doses of amiodarone. Report of three cases. (1986) (39)
- Low HCV replication levels in end-stage hepatitis C virus-related liver disease. (1999) (38)
- The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region. (2007) (38)
- Hepatitis B Vaccination in Diabetic Patients: Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen (1997) (37)
- Factors affecting treatment responses to interferon-alpha in chronic hepatitis C. (1996) (37)
- Idiopathic biliary ductopenia in adults: a report of five cases. (1990) (36)
- Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss. (1993) (36)
- Cocaine and the liver. (1991) (36)
- 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV (2016) (35)
- Antiviral Activity of ANA773, an Oral Inducer of Endogenous Interferons that Acts Via TLR7, in Chronic Hepatitis C Patients (2011) (35)
- Low‐grade steatosis and major changes in portal flow as new prognostic factors in steroid‐treated alcoholic hepatitis (2004) (35)
- Ascitic fluid pH in alcoholic cirrhosis: a reevaluation of its use in the diagnosis of spontaneous bacterial peritonitis. (1985) (34)
- Case Report: Terbinafine-Induced Prolonged Cholestasis with Reduction of Interlobular Bile Ducts (1997) (34)
- Effect of simvastatin, an inhibitor of hydroxy‐methylglutaryl coenzyme a reductase, on the growth of human ito cells (1994) (33)
- Chronic hyperbilirubinemia associated with hepatic uptake and storage impairment. A new syndrome resembling that of the mutant Southdown sheep. (1975) (33)
- Hepatitis C Virus in Dermatology (1995) (33)
- Hepatitis C Virus Quasispecies Variability Modulates Nonstructural Protein 5A Transcriptional Activation, Pointing to Cellular Compartmentalization of Virus-Host Interactions (2004) (32)
- Hepatic handling of unconjugated dyes in the Dubin-Johnson syndrome. (1973) (32)
- 68 Daily cannabis smoking as a risk factor for fibrosis progression in chronic hepatitis C (2004) (32)
- Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays. (1999) (31)
- The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. (1996) (31)
- A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C. (1996) (30)
- Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C. (1995) (29)
- Immunolocalization of heparinbinding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF‐2 in carbon tetrachloride‐induced fibrosis (1993) (29)
- Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C (1998) (29)
- Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily. (2007) (29)
- Evaluation of Liver Iron Content by Computed Tomography: Its Value in the Follow‐Up of Treatment in Patients with Idiopathic Hemochromatosis (2007) (28)
- Effect on Bile Formation of Inhibitors of Sodium Transport (1969) (28)
- Hepatic granulomas in Whipple's disease. (1984) (28)
- [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy]. (1991) (27)
- Acute fatal hepatitis related to sertraline. (2001) (27)
- Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding. (1984) (27)
- Effects of rose bengal on bile secretion in the rabbit: inhibition of a bile salt-independent fraction (1970) (26)
- [Prevalence of hepatitis C virus antibodies (tests ELISA 2 and RIBA 2) in a population of pregnant women in France]. (1992) (26)
- Toxicity of phorbol myristate acetate-stimulated polymorphonuclear neutrophils against rat hepatocytes. Demonstration and mechanism. (1988) (26)
- Cost‐effectiveness and budget impact of interferon‐free direct‐acting antiviral‐based regimens for hepatitis C treatment: the French case (2016) (26)
- [Focal nodular hyperplasia and hepatocellular adenoma in women. Current data]. (1997) (26)
- Spironolactone and enzyme induction in patients with alcoholic cirrhosis (1980) (25)
- Chronic hepatitis C virus and gastric MALT lymphoma. (1998) (24)
- Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis (1992) (24)
- A critical study of the concept of maximal biliary transport of sulfobromophtalein (BSP) in the Wistar rat. (1970) (24)
- GB virus C (GBV‐C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: Effect of interferon alfa therapy (1998) (24)
- Hepatitis C virus infection, mixed cryoglobulinemia, and B‐cell non‐Hodgkin's lymphoma (1999) (23)
- Chronic hepatitis C after high‐dose intravenous immunoglobulin (1994) (22)
- Reuse of a liver graft five days after initial transplantation. (1996) (22)
- New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias (1978) (22)
- Spontaneous portosystemic shunts in cirrhotics: implications for orthotopic liver transplantation. (1993) (22)
- Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis (2011) (21)
- Reinforced interferon alpha‐2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial (2003) (20)
- Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma (1995) (20)
- Computer-aided selection of diagnostic tests in jaundiced patients. (1985) (20)
- Biliary transport of cholephilic dyes: evidence for two different pathways. (1977) (20)
- Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha (1996) (20)
- Anti-HCV seroprevalence in pregnant women in France. (1993) (20)
- [Strategies of hepatitis C screening in general practice. Results of a two-center randomized trial]. (2000) (19)
- Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent. (2012) (19)
- Inhibitor against coagulation factor V after liver transplantation. (1999) (19)
- Significance of anti‐hepatitis C virus core IgM antibodies in patients with chronic hepatitis C (1995) (18)
- Hepatitis-associated antigen in human bile. (1971) (17)
- Emergency hepatic arterial embolization for secondary hypercalcemia in hepatocellular carcinoma. (1979) (17)
- Budd-Chiari syndrome and the lupus anticoagulant. (1985) (16)
- [A rare cause of portal vein thrombosis: closed abdominal trauma]. (1994) (16)
- Specificity of increased des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection. (1987) (16)
- Virological and biochemical responses to interferon-α in chronic hepatitis C (1994) (16)
- Copper and copper‐binding protein in liver tumors (1988) (16)
- Type I membranoproliferative glomerulonephritis and HCV infection. (1996) (16)
- Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis (2002) (15)
- [The effects of biliary drainage in cholestatic hepatitis]. (1970) (15)
- 49 LIFETIME COSTS ATTRIBUTABLE TO CHRONIC HEPATITIS C FROM THE FRENCH HEALTHCARE PERSPECTIVE (ANRS N°12188) (2013) (15)
- Hepatitis C virus prevention and care for drug injectors: the French approach (2018) (15)
- Measurement of hepatic blood flow in the rat. Trans-hepatic catheterization of the hepatic veins. (1973) (14)
- Liver transplantation for fulminant hepatitis following chemotherapy for malignant lymphoma (1990) (14)
- [Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases]. (1993) (14)
- Mouse hepatic endothelial cells in culture secrete a growth inhibitor for hepatic lipocytes and Balb/c 3T3 fibroblasts. (1989) (13)
- In vitro toxicity of hydrogen peroxide against normal vs. tumor rat hepatocytes: Role of catalase and of the glutathione redox cycle (1988) (13)
- [Transmission of hepatitis C by accidental needlestick injuries. Evaluation of the risk]. (1994) (13)
- [Prevalence of HBs antigen carriers and markers of B virus replication in a population of pregnant women, in France]. (1989) (12)
- [Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis]. (2004) (12)
- A computer-aided system for the diagnosis of hepato-biliary diseases. A comparison with the performance of physicians. (1979) (12)
- Role of bilirubin overproduction in revealing Gilbert's syndrome: is dyserythropoiesis an important factor? (1978) (12)
- Dibromsulphalein (DBSP) Estimation of Hepatic Transport Function in Man * (1974) (11)
- Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose. (1994) (11)
- [Hepatitis C virus infection. Epidemiology]. (1995) (11)
- Chronic hepatic encephalopathy due to spontaneous splenorenal shunt: Successful treatment by transhepatic shunt embolization (1994) (11)
- Epidemiologie et morbidité du virus de l'hépatite C en France : Etude de 6 664 patients atteints d'hépatite chronique C (1996) (10)
- The application of computer techniques to the laboratory diagnosis. Diseases of the liver and biliary system. (1971) (10)
- Unilobar small hepatic vein obstruction: Possible role of progestogen given as oral contraceptive (1983) (10)
- [Nodular regenerative hyperplasia of the liver. Study of 15 cases and review of the literature]. (1983) (10)
- Human liver plasma membrane Ca‐ATPase: Identification and sensitivity to calcium antagonists (1982) (9)
- Upper respiratory and digestive tract malignancies after liver transplantation for alcoholic cirrhosis. (1996) (9)
- Focal hemorrhagic necrosis of the liver. A clinicopathological entity possibly related to oral contraceptives. (1980) (9)
- HEPATITIS-C VIRUS (HCV) GENOTYPE DETERMINATION - GENOTYPING VERSUS SEROTYPING (1995) (9)
- Spironolactone and enzyme induction in patients with alcoholic cirrhosis. (1980) (9)
- Chemoembolization for hepatocellular carcinoma in cirrhotic patients: assessment of efficacy on total hepatectomy specimens. (1994) (9)
- Effects of propranolol on pulmonary gas exchange in patients with cirrhosis. (1989) (9)
- Hereditary conjugated hyperbilirubinaemia: 37 years later. (2013) (9)
- Measurement of gastric intramucosal pH in patients with cirrhosis and portal hypertensive gastropathy. (1994) (9)
- Hepatic calcification due to Fasciola gigantica. (1974) (9)
- Focal hemorrhagic necrosis of the liver: A clinicopathological entity possibly related to oral contraceptives (1980) (9)
- Demonstration of a basic fibroblast growth factor-like molecule in mouse hepatic endothelial cells. (1989) (9)
- Worsening of steatosis and fibrosis progression in hepatitis C (2003) (8)
- Coagulation Assays as Diagnostic Markers of Hepatocellular Carcinoma (1988) (8)
- Review article: HCV ? STAT-C era of therapy (2010) (8)
- Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic patients (1986) (8)
- Noradrenalin for treatment of type I hepatorenal syndrome (HRS) (2001) (8)
- [Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine]. (1986) (8)
- [Do general practitioners want to manage chronic hepatitis C and take part in hepatitis C health networks? A national survey]. (1999) (8)
- Significance of NS5‐“indeterminate” third‐generation anti‐hepatitis C virus serologic assays (1995) (8)
- [Non-A non-B, type C hepatitis]. (1990) (8)
- High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study. (1995) (8)
- Lichen planus, chronic hepatitis C, and interferon (1995) (8)
- Cystic dilatation of intrahepatic bile ducts in primary sclerosing cholangitis. (1990) (7)
- SERUM ANTIBODIES AGAINST DOUBLE-STRANDED DNA IN CHRONIC ACTIVE HEPATITIS: AN INDEX OF DRUG-INDUCED LIVER DISEASE? (1983) (7)
- O85 SHOULD WE AWAIT INTERFERON-FREE REGIMENS TO TREAT HCV GENOTYPE 1 TREATMENT-NAIVE PATIENTS? A COST-EFFECTIVENESS ANALYSIS (ANRS 12188) (2014) (7)
- Constitution rapide de calcifications intra-hépatiques au décours d'un syndrome HELLP (2002) (7)
- 62 Is ribavirin antiviral effect in humans mediated by mutagenic properties resulting in error catastrophe (2004) (7)
- [Hepatic transplantation for severe ductopenia related to ingestion of thiabendazole]. (1997) (7)
- [Chronic active hepatitis associated with anti-native DNA antibodies: incidence of drug etiology]. (1984) (7)
- Amiodarone-induced liver disease. (1989) (7)
- Nicardipine as antihypertensive therapy in liver transplant recipients: Results of long‐term use (1997) (7)
- [Chronic lesion of the interlobular bile ducts induced by fenofibrate]. (1994) (6)
- [Treatment of viral hepatitis C]. (1994) (6)
- Increased Gastric Bicarbonate Secretion in Portal Hypertensive Anesthetized Rats (Role of Prostaglandins and Nitric Oxide) (1997) (6)
- Hemochromatosis C282Y mutation and histological fibrosis in patients with C virus chronic hepatitis (1999) (6)
- [Hepatitis C in France]. (2002) (6)
- Unilobar small hepatic vein obstruction: possible role of progestogen given as oral contraceptive. (1983) (6)
- Unusual hepatic venous drainage in inferior vena cava obstruction: demonstration by MRI. (1986) (6)
- [Chenodeoxycholic acid treatment of gallstones: a survey of 25 patients (author's transl)]. (1978) (6)
- [Non-A, non-B viral hepatitis]. (1984) (6)
- Effect of phenobarbital in a case of extrahepatic cholestasis. (1975) (6)
- P.228 Assessment of ribavirin mutagenic properties in vivo and the influence of interferon alpha-induced reduction of hepatitis C virus RNA load upon therapy (2006) (6)
- Characterization of two human monoclonal IgM antibodies that recognize nuclear lamins (1992) (6)
- [Congenital cystic diseases of the intra and extrahepatic bile ducts]. (2005) (6)
- [Comparison of the effects of cimetidine and ranitidine in vivo and in vitro on the hepatic microsomal enzyme system in rats]. (1983) (5)
- [Assessment of hepatic fibrosis: what is the role of non-invasive markers in 2003?]. (2003) (5)
- Trends of hepatitis C screening in France through Rena-VHC and hepatology reference centres surveillance systems, 2000-2007. (2009) (5)
- AASLD AbstractAre hepatitis C virus genotypes 1a and 1b so diffrent (1995) (5)
- CONSTITUTIONAL UNCONJUGATED HYPERBILIRUBINÆMIA (1977) (5)
- Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: Evidence for a role of HCV genotype 3 in steatosis (2003) (5)
- [The liver and vitamin A]. (1985) (5)
- Are hepatitis C virus genotypes 1a and 1b so different? (1996) (5)
- Fracture of biliary endoprosthesis after endoscopic drainage for malignant biliary obstruction. Report of two cases. (1986) (4)
- Toxicity of polymorphonuclear neutrophils against hepatocytes: protective effect of heparin. (1989) (4)
- Other clinical studyHuman myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver (1995) (4)
- [Hepatic resection for Caroli's disease limited to the left liver. Fortuitous disclosure of cholangiocarcinoma]. (1983) (4)
- Is the detection of anti‐hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor? (1995) (4)
- Histological evaluation of alpha 2a interferon monotherapy in patients with chronic hepatitis C and repeatedly normal aminotransferase levels. A randomized study (2001) (4)
- Diagnosis of HCV recurrence after liver transplantation using branched DNA assay for HCV RNA quantitation. (1994) (4)
- Hepatitis C virus NS3 serine protease variability and evolution are strongly constrained by the need for structural and functional conservation (2002) (4)
- SALIVARY-GLAND LESIONS IN PATIENTS WITH CHRONIC HEPATITIS-C (1994) (4)
- Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alfa efficacy in chronic hepatitis C: A wrong track (2000) (4)
- Should the patients with histologically mild chronic hepatitis C betreated (2000) (4)
- [Treatment of hepatitis C: advances and consensus]. (2002) (3)
- [Fast appearance of intra-hepatic calcifications following a case of HELLP syndrome]. (2002) (3)
- Factors associated with recurrence after transplantation for hepatocellular carcinoma (2003) (3)
- [Hepatic fibrosis and portal hypertension in chronic vitamin A poisoning]. (1984) (3)
- [Clinical symptomatology and radiological aspects of primary cancers of the liver]. (1992) (3)
- [Anti-mitochondria antibodies with an anti-M aspect, in Q fever]. (1984) (3)
- Decreased toxicity of polymorphonuclear neutrophils toward hepatocytes isolated from rats with acute inflammatory reaction (1990) (3)
- [Prevalence of hepatitis C virus infection in pregnant woman on the island of Réunion]. (1999) (3)
- Hepatitis B infection: estimation of the annual number of newly infected cases in France, 2004-2007. (2009) (3)
- Alpha 2A interferon monotherapy in patients with chronic hepatitis C and repeatedly normal aminotransferase levels (2000) (3)
- Serum anti-liver cytosol antibodies type 1 in hepatitis C virus infection. (1994) (3)
- [Tienilic acid can induce acute hepatitis, chronic hepatitis and cirrhosis. A report of three cases (author's transl)]. (1981) (3)
- A French consensus conference on hepatitis C: screening and treatment. (1997) (3)
- Prediction of survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) using the TNM staging classification modified for LT: Validation in a French cohort (2003) (3)
- [Auxiliary hepatic transplantation in iproniazid-induced subfulminant hepatitis. Should iproniazid still be sold in France?]. (1999) (3)
- [Double liver-kidney transplantation in the presence of a positive T cross-match]. (1992) (3)
- 809 IMMEDIATE OR DELAYED TREATMENT INITIATION WITH “PREVIR” CONTAINING REGIMENS IN HCV-INFECTED NAIVE GENOTYPE 1 (G1) PATIENTS WITHOUT SEVERE FIBROSIS? A COST-EFFECTIVENESS ANALYSIS (ANRS N°12188) (2013) (2)
- Liver diseases associated with autoantibodies directed to nuclear envelope components (1989) (2)
- 1362 THE AVAILABILITY OF DIRECT ACTING ANTIVIRALS (DAA) IN 2012: A FRENCH MODEL-BASED ANALYSIS OF THE INCREASED NUMBER OF PATIENTS TREATED FOR CHRONIC HCV INFECTION (2011) (2)
- Constitutional unconjugated hyperbilirubinaemia. (1977) (2)
- 605 Viral steatosis is not related to fibrosis severity in patients with chronic hepatitis C (2003) (2)
- Liver iron overload in patients with chronic active hepatitis C. Prevalence, role of the hemochromatosis gene and relation with hepatic histological lesions (1998) (2)
- [2 cases of cirrhosis in patients treated with amiodarone]. (1985) (2)
- [Hepatic cholesterol ester storage disease. Two new cases diagnosed in adults]. (1991) (2)
- [Iron overload and liver diseases (except for hemochromatosis and dysmetabolic hepatosiderosis]. (2000) (2)
- [Nuclear envelope autoantibodies and liver diseases]. (1990) (2)
- [Chronic active hepatitis]. (1995) (2)
- The thymol turbidity test and determination of serum cholesterol : two tests to abandon in the routine evaluation of liver function. (1978) (2)
- Factor predictive of a response to interferrcn cherapy in NANB chronic active hepatitis (1990) (2)
- Pentoxifylline inhibits the proliferation and the fibrogenic properties of human hepatic myofibroblastic cells (1995) (2)
- [Biliary secretion of rabbit: evidence in favor of important fraction independent of bile salts]. (1969) (2)
- Post-transplant lymphoproliferative disorders (PTLD) after liver transplantation (LT). Role of HCV infection (1998) (1)
- Hepatitis C virus (HCV)‐related cryoglobulinemia after liver transplantation for HCV cirrhosis (2002) (1)
- Congenital Erythropoietin-Dependent Erythrocytosis Responsive to Theophylline Treatment (1998) (1)
- Use of denatuning gradient gel electrophoress (DGGE) for studying the gentic variability of hepattits B virus (1990) (1)
- [Microvacuolar steatosis following low doses of doxycycline]. (2002) (1)
- 634 Assessment of biliary fibrosis by transient elastography in PBC and PSC patients (2006) (1)
- [Hepatitis C virus ten years after its discovery]. (1999) (1)
- [Diagnosis of cholestasis]. (1982) (1)
- Non virological factors associated with fibrosis progression after hepatitis C virus (HCV) graft reinfection (2002) (1)
- [The G virus: the orphan virus]. (1999) (1)
- Alcohol intake, even moderate, induces increased histological activity and fibrosis in patients with chronic active hepatitis C (1998) (1)
- Prognostic factors associated with liver transplantation (LT) for hepatocellular carcinoma (HCC) (2001) (1)
- Survival benefit associated with liver transplantation (LT) in patients transplanted for hepatocellular carcinoma (HCC) (2001) (1)
- Are basal core-IgM antibodies to hepatitis C virus predictive of successful alpha-interferon therapy? (1995) (1)
- Tampon use as a cause of recurrent cholestatic jaundice. (1982) (1)
- Is ursodeoxycholic acid an effective treatment for primary sclerosing cholangitis (1989) (1)
- [The metabolic clearance rate of antipyrine: a good index for the assessment of the hepatic drug-oxidizing function in cirrhotic patients (author's transl)]. (1978) (1)
- Clinical significance of HCV core antigen, a new marker of HCV infection (2002) (1)
- [ The mobilization of an entire discipline around a white book: why?]. (2001) (1)
- 1150 Dynamics and early diagnosis of HBV resistance to lamivudine: a thorough quasispecies analysis (2003) (1)
- [Treatment of chronic hepatitis C: present and future]. (2000) (1)
- [Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France (author's transl)]. (1979) (1)
- [Non-A non-B acute hepatitis]. (1990) (1)
- [Acarbose-induced acute hepatitis]. (1999) (1)
- Special Issue - Surveillance and prevention of hepatitis B and C in France: assessment and prospects. (2009) (1)
- Acute inflammatory reaction promotes resistance of hepatocytes to polymorphonuclear cell toxicity (1989) (1)
- [Vigabatrin-induced cytolytic hepatitis]. (2001) (1)
- Myasthenia gravis and hepatitis C virus infection (1994) (1)
- Ascitic fluid pHinalcoholic cirrhosis: areevaluation of its useinthediagnosis ofspontaneous bacterial peritonitis JSCEMAMA-CLERGUE,C DOUTRELLOT-PHILIPPON, J-MMETREAU, (1985) (1)
- [Effect of spironolactone on bile formation and liver microsomal enzymic activities in the rat (author's transl)]. (1977) (1)
- [Steasis and hepatitis C]. (2003) (0)
- [Tomodensitometry of the liver and biliary tracts]. (1980) (0)
- Gastric malt lymphoma : a pathogenetic role of hepatitis C virus (HCV)? (1998) (0)
- Study on the risk perception of viral hepatitis B and its vaccine prevention among people consulting in a free and anonymous screening centre (CDAG), 2007, Paris, France. (2009) (0)
- Are there risk factors other than genotype associated to hepatitis Cvirus (HCV) recurrence after liver transplantation (LT) (2000) (0)
- Steatosis is associated with worse histological activity and fibrosis in patients with chronic hepatitis C (2001) (0)
- Congenital abnormalities of the biliary tract (2012) (0)
- [Nonconjugated hyperbilirubinemia of drug origin and hepatic glucuro-conjugation]. (1971) (0)
- Evolution of risk factors and characteristics of patients with chronic hepatitis C between 1990 and 1997 in an urban area in France (1998) (0)
- Adjuvant chemotherapy and radiotherapy in liver transplantation for primary hepatocellular carcinoma: a feasibility study (1994) (0)
- [Reticulosarcoma of the small intestine revealed by malabsorption syndrome]. (1970) (0)
- Overt B-cell non-Hodgkin's lymphoma (B-NHL): Role of hepatitis C virus (HCV) (2000) (0)
- Detection of hepatic injury in multiple trauma (1976) (0)
- [Diagnostic difficulties in a case of visceral leishmaniasis observed in Paris. Hepatic manifestations of visceral leishmaniasis]. (1970) (0)
- Evaluation de la fibrose hépatique (2008) (0)
- A basic fibroblast growth factor-like molecule synthetized by hepatic sinusoidal endothelial cells may regulate Ito cell proliferation (1989) (0)
- [Iron and chronic liver disease (excluding genetic hemochromatosis and metabolic liver siderosis)]. (2000) (0)
- Prolifération lymphocytaire et virus de l'hépatite C (1999) (0)
- Gastric malt lymphoma: Pathogenetic role of hepatitis C virus (1998) (0)
- [The role of virologic tests in the treatment of chronic hepatitis C]. (1999) (0)
- [Acanthocytosis in cirrhosis. Report of four cases and review of the literature (author's transl)]. (1977) (0)
- [Biliary calcinosis and fibrous dystrophy of the neck of the gallbladder in a 29-year-old man]. (1996) (0)
- Evaluation of liver iron content by computerized tomography its interest for the follow up of treated patients with idiopathic hemo chromatosis (1982) (0)
- Steatosis, fibrosis and hepatitis C virus infection (2010) (0)
- [Pegylated interferons: pharmacological basis]. (2002) (0)
- Hepatitis Cvirus infection can mimictype1 (antinuclear antibody positive) autoimmune (1993) (0)
- Dibromsulphalein (DBSP) Estimation of Hepatic Transport Function in Man * (1974) (0)
- [Hepatic glucurono-conjugation of phthaleins. Study in the Wistar rat and the homozygous Gunn rat]. (1968) (0)
- Newinsights into theclassification andmechanisms ofhereditary, chronic, non-haemolytic hyperbilirubinae (1978) (0)
- Hepatitis C virus iukction and autoimnune thrornbocytope& purpura (1995) (0)
- 1189 Mechanisms of ribavirin early antiviral effect in chronic hepatitis C: is it related to ribavirin mutagenic properties inducing? Error catastrophe? (2003) (0)
- Does HCV core antigen detection in graft donors improve organ transplantation viral safety (2001) (0)
- [Severe hepatitis caused by phenobarbital]. (1994) (0)
- Virological and biochemical responses to interferon-alpha in chronic hepatitis C. (1994) (0)
- An outbreak of B virus hepatitis in diabetic patients. Role of an automatic device used for glucose estimations (1989) (0)
- [Chronic hepatitis C with repeatedly normal transaminase levels]. (2002) (0)
- [Chronic viral hepatitis B and C. Epidemiology, diagnosis, etiology, prevention]. (2001) (0)
- [Primary biliary cirrhosis and Biermer's anemia]. (1980) (0)
- P1227 : Intra-hepatic Cholestasis of Pregnancy (ICP): Prevention of recurrence of ICP and intra uterine fetal death by pre-pruritus administration of ursodeoxycholic acid (2015) (0)
- [Which precautions should be taken in case of hepatitis C? From the statement of the question to the dissemination of the response in a consensus conference]. (1998) (0)
- genotyping assay . genotype : comparison with a standardized Serological determination of hepatitis C virus (1997) (0)
- [Biological and clinical study of diffuse atrophy of the small intestine]. (1967) (0)
- P.203 Colocalization of HCV core protein with intracellular lipid droplets occurs regardless of the HCV genotype and the steatogenic character of HCV strains (2006) (0)
- Effect ofrifampicin on liver function inman (1972) (0)
- Dynamics of lamivudine-resistant HBV mutants: a quasispecies analysis (2002) (0)
- Gamma-glutamyltranspeptidase in cholestasis. An histochemical, biochemical and molecular approach using two experimental models (1989) (0)
- [Towards early screening and treatment of hepatocellular carcinoma cirrhosis?]. (2002) (0)
- Functional consequences of HCV quasispecies distribution: transcriptional activation by HCV non structural 5A (NS5A) protein is quasispecies-dependant (2001) (0)
- Antinuclear Autoantibodies Specific for Lamins (2020) (0)
- Factors associated with steatosis and relationship between steatosis and the severety of the disease in patients with chronic hepatitis C (2002) (0)
- Mixed cryoglobulinemia after liver transplantation (LT) for HCV cirrhosis. Prevalence and features (1998) (0)
- Can histological factors predict evolution towards severe fibrosis in recurrent hepatitis C after liver transplantation (2001) (0)
- [The treatment of viral hepatitis]. (1991) (0)
- Non-structural 5A (NS5A) protein and HCV genotype 3a sensitivity to interferon (IFN)-alpha therapy (2001) (0)
- Subject Index, Vol. 7, 1972 (1972) (0)
- SPECIFICITY OF INCREASED DES-GAMMA-CARBOXYPROTHROMBIN AS A MARKER OF HEPATOCELLULAR CARCINOMA AFTER VITAMIN K INJECTION (1987) (0)
- HCV genotype 1 resistance to interferon (IFN) afla antiviral effect: Role of the nonstructural NS5A protein and the putative ISDR (2003) (0)
- Steatosis evolution is a main determinant of fibrosis progression in untreated patients with chronic hepatitis C (2002) (0)
- [Drug-induced chronic hepatitis and cirrhosis]. (1993) (0)
- Maximal biliary transport of sulfobromophthalein in the Wistar rat. A critical study. (1971) (0)
- Dynamic quasispecies analysis of YMDD mutants in patients with chronic hepatitis B resistant to lamivudine (2003) (0)
- [Infected ascites in the cirrhotic patient: toward prevention?]. (1987) (0)
- Prevalence and prognostic significance of portal blood flow reversionin severe steroid-treated alcoholic hepatitis (2000) (0)
- [Comparative study of pinocytosis and the production of prostaglandin E2 by hepatic and peritoneal resident macrophages in mice]. (1985) (0)
- 483 Metabolic, but not virus-induced steatosis, is related with liver disease severity in chronic hepatitis C (2004) (0)
- Steroid withdrawal in cyclosporin a (CSA)-treated liver transplant(LT) recipients. Pathological and biochemical assessment (2000) (0)
- 419 Hepatitis C virus genotype 3, but not genotype 1, is cytopathic, steatogenic (2003) (0)
- [Prion diseases, the liver and the digestive system]. (1999) (0)
- Authors’ Index, Vol. 7, 1972 (1972) (0)
- 117 Liver transplantation for hepatocellular carcinoma: A new prognostic score predicting disease-free survival (2004) (0)
- [Severe hepato-cellular insufficiency and renal insufficiency in a 66-year-old woman]. (1980) (0)
- [Hepatitis B. Epidemiology, etiology, diagnosis, development, prognosis, principles of treatment]. (1992) (0)
- Effect of tobacco consumption on hepatic histological lesions in patients with chronic hepatitis C (2000) (0)
- Contents, Vol. 7, 1972 (1972) (0)
- [Epidemiology of hepatitis C in France: from transfusion to drug addiction]. (1994) (0)
- [Thrombosis of the smaller hepatic veins. Diagnostic value of retrograde hepatic phlebography]. (1972) (0)
- [Results of and indications for chenodesoxycholic acid in vesicular lithiasis (proceedings)]. (1977) (0)
- Cost-Effectiveness and Budget Impact of Interferon-Free Direct-Acting Antiviral (DAA)-Based Regimens for Chronic Hepatitis C Treatment. The French Case (2016) (0)
- The majority of liver transplant recipients with normal liver enzymetests (LET) exhibit long term liver graft lesions (2000) (0)
- [Mechanisms of drug-induced hepatitis]. (1990) (0)
- Relationship between steatosis and fibrosis in chronic hepatitis C: Effect of HCV genotype (2003) (0)
- Perception and knowledge of virral hepatitis: results of the Nicolle Survey, France, 2006. (2009) (0)
- [Clinical hepatology at the dawn of the year 2000]. (2000) (0)
- [Results of the treatment with biliary dissolvents]. (1992) (0)
- Are there risk factors other than genotype associated to hepatitis C virus (HCV) recurrence after liver transplantation (LT) (2000) (0)
- Reply: (2007) (0)
- [Detection of hepatic lesions in patients with multiple injuries. Value of the determination of blood glutamo-pyruvic transaminase]. (1975) (0)
- Initial clinical patterns of hepatitis C virus reinfection after liver transplantation for hepatitis C virus-related cirrhosis. (1996) (0)
- [Diagnostic value and meaning of radiocopper loading test abnormalities in Wilson's disease (author's transl)]. (1982) (0)
- Compensated viral cirrhosis: descriptive analysis of 774 first patients included in a prospective French cohort (ANRS CO12 CirVir). (2009) (0)
- Representations of hepatitis C treatment among drug users. InVS-ANRS Coquelicot Survey, France, 2004-2007. (2009) (0)
- [Hepatitis during treatment with ketoconazole]. (1984) (0)
- [Diagnosis with a computer. Preliminary results of an application to liver diseases and bile duct diseases]. (1970) (0)
- Edinburgh Research Explorer Serological determination of hepatitis C virus genotype (1997) (0)
- First International Gstaad Symposium: The Liver Quantitative Aspects of Structure and Function (1972) (0)
- [Treatment of chronic hepatitis C]. (1995) (0)
- [Jaundice and rifampicin. Critical study]. (1974) (0)
- Acute inflaxxatory reaction protects against corynebacterium parvum/endotoxin-induced hepatitis (1990) (0)
- 585 Major changes in portal blood flow and low grade steatosis as new pronostic factors in corticosteroid treated patients with alcoholic hepatitis (2004) (0)
- The majority of liver transplant recipients with normal liver enzyme tests (LET) exhibit long term liver graft lesions (2000) (0)
This paper list is powered by the following services: